EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Combined HDL–BMI Phenotyping Provides Incremental Prognostic Value in Idiopathic Pulmonary Fibrosis

Qinxue Shen, Xiaoli Ouyang, Yuexin Tan, Qing Zhang, Feng Hu, Shengyang He, Hong Peng iD

Journal of Clinical Medicine · 26.03.2026 · 15 (7) · 2525

DOI: 10.3390/jcm15072525 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 26.03.2026. Verfasst von Qinxue Shen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, The Second Xiangya Hospital, Central South University, Changsha 410011, China. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Clinical Specialty Construction Projects of China, National Natural Science Foundation of China, Natural Science Foundation of Chang Sha.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Risk stratification in idiopathic pulmonary fibrosis (IPF) remains primarily based on physiological indices, yet increasing evidence suggests that systemic metabolic and nutritional vulnerability may influence outcomes in chronic interstitial lung disease.

Methods

In this longitudinal, single-center cohort, 211 patients with IPF were followed from diagnosis until death or last follow-up. Baseline lipid profiles and body mass index (BMI) were assessed. A metabolic–nutritional phenotype was constructed using high-density lipoprotein cholesterol (HDL) and BMI. Survival was analyzed using Kaplan–Meier and multivariable Cox models adjusted for GAP stage. Incremental prognostic value beyond the GAP index was evaluated using Harrell’s C-index and time-dependent ROC analysis.

Results

During a median follow-up of 29 months, 134 patients (63.5%) died. Lower HDL levels were associated with increased mortality in unadjusted analysis (HR = 1.45, 95% CI 1.03–2.04) but were not independently predictive after adjustment. In contrast, the combined HDL–BMI phenotype independently stratified mortality risk. Compared with HDL ≤ 1.0 mmol/L and BMI ≤ 24 kg/m2, patients with HDL > 1.0 mmol/L and BMI > 24 kg/m2 had significantly lower mortality (adjusted HR = 0.48, 95% CI 0.29–0.80), with stronger associations among those aged ≥ 65 years (adjusted HR = 0.37, 95% CI 0.18–0.74). The addition of HDL–BMI improved discrimination beyond GAP (C-index: 0.585 vs. 0.618; 36-month AUC: 0.633 vs. 0.675; NRI: 0.243).

Conclusions

The coexistence of HDL ≤ 1.0 mmol/L and BMI ≤ 24 kg/m2 identified a subgroup with poorer survival in IPF. This combined metabolic–nutritional phenotype improved mortality risk stratification beyond the GAP stage.

Schlagwörter

Stichwörter der Autor:innen

HDL–BMIchronic disease prognosisidiopathic pulmonary fibrosisnutritional vulnerability

Autor:innen und Institutionen

  • Department of Pulmonary and Critical Care Medicine, The Second Xiangya Hospital, Central South University, Changsha 410011, China.
  • Research Unit of Respiratory Disease, Central South University, Changsha 410011, China.
  • The Clinical Medical Research Center for Pulmonary and Critical Care Medicine in Hunan Province, Changsha 410011, China.
  • Diagnosis and Treatment Center of Respiratory Disease, Central South University, Changsha 410011, China.
  • Clinical Medical Research Center for Systemic Autoimmune Diseases in Hunan Province, Changsha 410011, China.

ORCID-Profile: Hong Peng

Förderung

  • National Key Clinical Specialty Construction Projects of China
  • National Natural Science Foundation of China
  • Natural Science Foundation of Chang Sha
  • National Natural Science Foundation of China https://ror.org/01h0zpd94

Zitieren

APA

Shen, Q., Ouyang, X., Tan, Y., Zhang, Q., Hu, F., He, S., & Peng, H. (2026). Combined HDL–BMI Phenotyping Provides Incremental Prognostic Value in Idiopathic Pulmonary Fibrosis. Journal of Clinical Medicine, 15(7), 2525. https://doi.org/10.3390/jcm15072525

Vancouver

Shen Q, Ouyang X, Tan Y, Zhang Q, Hu F, He S, et al. Combined HDL–BMI Phenotyping Provides Incremental Prognostic Value in Idiopathic Pulmonary Fibrosis. Journal of Clinical Medicine. 2026;15(7):2525. doi:10.3390/jcm15072525

BibTeX
@article{Shen2026,
  author = {Shen, Qinxue and Ouyang, Xiaoli and Tan, Yuexin and Zhang, Qing and Hu, Feng and He, Shengyang and Peng, Hong},
  title = {Combined HDL–BMI Phenotyping Provides Incremental Prognostic Value in Idiopathic Pulmonary Fibrosis},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {7},
  pages = {2525},
  doi = {10.3390/jcm15072525}
}
Kostenlos starten →